Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagonist Therapeutics

42.97
-0.9500-2.16%
Post-market: 42.970.00000.00%16:08 EDT
Volume:671.23K
Turnover:29.31M
Market Cap:2.66B
PE:49.82
High:45.43
Open:44.15
Low:42.85
Close:43.92
Loading ...
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 11, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]